Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Eyes Have It

Jason Liebowitz, MD, FACR  |  Issue: December 2023  |  November 14, 2023

Posterior uveitis is among the rarer forms of uveitis, but it is also the form of uveitis that can be most associated with loss of vision. The challenge with this condition is that visual symptoms may occur even in the absence of significant pain. Among the infections that can cause posterior uveitis are syphilis, toxoplasmosis, tuberculosis, endogenous endophthalmitis and viral causes, such as herpes simplex virus, herpes zoster virus and cytomegalovirus. Vision loss in posterior uveitis can occur quickly, and it may be necessary to rapidly escalate therapy to include one or more medications, such as methotrexate and/or mycophenolate mofetil.

Panuveitis is a generalized inflammation that includes the whole of the uveal tract, as well as the retina and vitreous humor. Dr. Kopplin said this particular form of uveitis can be seen in patients with sarcoidosis. Like the other forms of uveitis, infectious causes must be excluded, in particular with testing for syphilis and tuberculosis. Lyme testing may be indicated for patients with various forms of uveitis, although this depends on the geographic location of the patient (i.e., if it is a Lyme-endemic area). In Dr. Kopplin’s opinion, there is a limited role for testing for toxoplasma and toxocara in most patients with uveitis.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Several uveitis syndromes are restricted to the eye. These include sympathetic ophthalmia, birdshot retinopathy, serpiginous chorioretinopathy and pars planitis. Because many of these conditions may require use of systemic immunosuppressive treatments, it is important that rheumatologists be aware of them. Rheumatologists may be called upon to manage medications for these patients while collaborating with ophthalmologists.

Other Inflammatory Eye Diseases

Moving on to other forms of inflammatory eye disease, Dr. Kopplin explained that scleritis can be diagnosed with an exam using natural light alone. Patients with scleritis will often describe a “toothache-like” pain in the eye. There is often scleral injection with a purplish hue on exam, and scleritis is very frequently due to an underlying systemic inflammatory condition. Rheumatoid arthritis is a common culprit, but entities like hepatitis, IgG4-related disease and bisphosphonate-induced scleritis are possible as well.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Episcleritis is often self-limited and is not generally associated with a great deal of pain.

Dr. Kopplin also mentioned orbital inflammatory conditions, which may include dacryoadenitis, ocular myositis and inflammation of the orbital fatty tissue.

Across uveitis, scleritis and episcleritis, an underlying cause may not be found in a substantial number of patients, and the condition is then regarded as idiopathic.

Page: 1 2 3 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsOther Rheumatic Conditions Tagged with:ACR Convergence 2023panuveitisUveitis

Related Articles

    Watch Those Eyes

    December 1, 2007

    What you need to know about Uveitis in Rheumatic Diseases

    Scleritis Often Diagnosed by Ophthalmologists, But Rheumatologists Help Determine Systemic Causes

    March 15, 2016

    Ophthalmologists may be more likely to initially diagnose and treat scleritis, an inflammation of the scleral tissues of the eye. However, rheumatologists need to remain aware of the condition as well: It’s commonly associated with rheumatic disorders, such as rheumatoid arthritis (RA). Scleritis can present in the eye anteriorly or posteriorly. “Anterior scleritis can be…

    An Overview of Pediatric, Noninfectious Uveitis

    October 18, 2018

    Uveitis is an inflammation of the uvea, which comprises the iris, ciliary body and choroid. Uveitis can lead to ocular damage and complete visual loss. Noninfectious etiologies for uveitis are the most common in the U.S.1 The estimated incidence of uveitis ranges from 25–52 per 100,000 in adults and five per 100,000 in children. The…

    ARZTSAMUI / shutterstock.com

    Uveitis: A Brief Primer for the Rheumatologist

    November 12, 2020

    Uveitis is an umbrella term for intraocular inflammatory diseases that can lead to vision loss. It’s not just a concern for ophthalmologists. Uveitis occurs in approximately 2–5% of patients with inflammatory bowel disease, 6–9% of patients with psoriatic arthritis and 25% of patients with reactive arthritis. The prevalence may be as high as 33% in…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences